Northwest Biotherapeutics, Inc. announced that Mr. Jerry Jasinowski retired from the Board of Directors of the company on March 8, 2024, after more than a decade of service on the Board. Mr. Jasinowski, aged 85, retired due to health reasons and not due to any disagreement with the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.491 USD | +0.61% | +9.11% | -29.96% |
10/05 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
21/03 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-29.96% | 593M | |
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- NWBO Stock
- News Northwest Biotherapeutics, Inc.
- Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors